C12Y 304/21046
Complement factor d
Official title: Complement factor D (3.4.21.46)
C12Y304/21046 (Complement factor d) appears on 6 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 9
- Assignees
- 5
- Inventors
- 25
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 1 | 4 |
| 2018 | 0 | 2 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Complement factor D antagonist antibodies and conjugates thereof11 Nov 2025US 12,466,879 B2Kodiak Sciences Inc.
- Complement factor D antagonist antibodies and conjugates thereof21 Feb 2023US 11,584,790 B2Kodiak Sciences Inc.
- Compositions and methods for regulating pancreatic beta cell function using adipsin17 May 2022US 11,331,379 B2Dana-Farber Cancer Institute, Inc.
- Methods of measuring factor D activity and potency of factor D inhibitors17 Mar 2020US 10,591,481 B2Genentech, Inc.
- Compositions and methods for regulating pancreatic beta cell function using adipsin25 Jun 2019US 10,328,131 B2Dana-Farber Cancer Institute, Inc.
- Treatment Of Macular Degeneration With Complement Factor D (CFD) Inhibitors24 Apr 2025US 2025/0129371 A1Regeneron Pharmaceuticals, Inc.
- Complement factor d antagonist antibodies and conjugates thereof30 Nov 2023US 2023/0382983 A1Kodiak Sciences Inc.
- Compositions and methods for regulating pancreatic beta cell function using adipsin26 Mar 2020US 2020/0093900 A1Dana-Farber Cancer Institute, Inc.
- Compositions and methods for treating and diagnosing ocular disorders29 Nov 2018US 2018/0338952 A1Translatum Medicus Inc.
- Complement factor d antagonist antibodies and conjugates thereof22 Nov 2018US 2018/0334496 A1Kodiak Sciences Inc.
Most cited
By later US patents
- Complement factor D antagonist antibodies and conjugates thereof6US 11,584,790 B2Kodiak Sciences Inc. · 2023
- Compositions and methods for regulating pancreatic beta cell function using adipsin1US 10,328,131 B2Dana-Farber Cancer Institute, Inc. · 2019
- Methods of measuring factor D activity and potency of factor D inhibitors1US 10,591,481 B2Genentech, Inc. · 2020
- Complement factor D antagonist antibodies and conjugates thereof1US 12,466,879 B2Kodiak Sciences Inc. · 2025